217 filings
Page 3 of 11
ARS
jrdmw0jkn466y4v
29 Apr 08
Annual report to shareholders
12:00am
8-K
l4otc9zxso64k
24 Apr 08
AtheroGenics Reports First Quarter 2008 Financial Results
12:00am
8-K
dw7zcu444o p15
14 Apr 08
AtheroGenics Announces Encouraging Interim Results from
12:00am
8-K
6e49b8a89q8rj
7 Apr 08
Entry into a Material Definitive Agreement
12:00am
8-K
ms51k
4 Mar 08
Other Events
12:00am
UPLOAD
so9rrv9hc0 hrhmto
26 Feb 08
Letter from SEC
12:00am
8-K
xuqu9d weffvi34
14 Feb 08
AtheroGenics Reports Fourth Quarter and Year-End 2007 Financial Results
12:00am
CORRESP
3727107
14 Jan 08
Correspondence with SEC
12:00am
8-K
s000n2xlcjl sd5gizmi
9 Jan 08
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am
8-K
sne3eu
2 Jan 08
AtheroGenics Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market
12:00am
UPLOAD
qb28q 9y6s
27 Dec 07
Letter from SEC
12:00am
8-K
nw66k 0effy
18 Dec 07
AtheroGenics Completes Enrollment in ANDES Phase III Clinical Trial of AGI-1067
12:00am
8-K
jooi1d9 20xi00vmc5pm
3 Dec 07
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
a30inw
3 Dec 07
Other Events
12:00am
8-K
4n7jxd1kiapzjfw 3wt
19 Nov 07
Departure of Directors or Principal Officers
12:00am
8-K
ht6h2j bbg32me6dofj
15 Nov 07
Other Events
12:00am